Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-644.78%
operating margin TTM
-634.2%
revenue TTM
1.78 Million
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.76 |
| peg ratio | -0.06 |
| price to book ratio | 1.05 |
| price to sales ratio | 5.23 |
| enterprise value multiple | -0.65 |
| price fair value | 1.05 |
profitability ratios | |
|---|---|
| gross profit margin | 97.55% |
| operating profit margin | -634.2% |
| pretax profit margin | -644.78% |
| net profit margin | -644.78% |
| return on assets | -67.15% |
| return on equity | -93.94% |
| return on capital employed | -77.86% |
liquidity ratio | |
|---|---|
| current ratio | 5.44 |
| quick ratio | 5.44 |
| cash ratio | 1.47 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 110.94 |
| operating cycle | 151.73 |
| days of payables outstanding | 7,108.38 |
| cash conversion cycle | -6,956.65 |
| receivables turnover | 8.95 |
| payables turnover | 0.05 |
| inventory turnover | 3.29 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.36 |
| debt equity ratio | 0.74 |
| long term debt to capitalization | 0.41 |
| total debt to capitalization | 0.43 |
| interest coverage | -12.65 |
| cash flow to debt ratio | -1.65 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.53 |
| cash per share | 0.70 |
| operating cash flow per share | -0.52 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -1.65 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -173.40 |
Frequently Asked Questions
When was the last time Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) reported earnings?
Lexicon Pharmaceuticals, Inc. (LXRX) published its most recent earnings results on 13-11-2024.
What is Lexicon Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)'s trailing twelve months ROE is -93.94%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Lexicon Pharmaceuticals, Inc. (LXRX) currently has a ROA of -67.15%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did LXRX's net profit margin stand at?
LXRX reported a profit margin of -644.78% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is LXRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.44 in the most recent quarter. The quick ratio stood at 5.44, with a Debt/Eq ratio of 0.74.